Satoshi Kobayashi

Neoadjuvant Oxaliplatin and Capecitabine and Bevacizumab without Radiotherapy for Poor-risk Rectal Cancer: N-SOG 03 Phase II Trial

Keisuke Uehara, Kazuhiro Hiramatsu, Atsuyuki Maeda et al. · Japanese Journal of Clinical Oncology · 2013 · 144 citations · Full text

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).

Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto et al. · Journal of Clinical Oncology · 2022 · 103 citations

Immunology, Pathology, Aggressive Tumor Biology +21

Dynamic CT of Hepatic Abscesses

Toshifumi Gabata, Masumi Kadoya, Osamu Matsui et al. · American Journal of Roentgenology · 2001 · 85 citations

Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study

T. Kamiya, Keisuke Uehara, Goro Nakayama et al. · European Journal of Surgical Oncology · 2016 · 54 citations

Surgical Oncology, Radiation Therapy, Medicine +8

Cholecystectomy in octogenarians: be careful

Yasuyuki Fukami, Yasuhiro Kurumiya, Keisuke Mizuno et al. · Updates in Surgery · 2014 · 49 citations

Biliary Tract, Gastroenterology, Biliary Disorder +4